Work

Pos0244 Long-term Improvements in Serum Uric Acid Levels, Gout Symptoms, and Safety up to 12-months With Sel-212 in Gout Refractory to Conventional Therapy: Results From the Dissolve I Phase 3, Double-blind, Placebo-controlled Clinical Trial

Year: 2024

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2024-eular.2875

Authors: A. Kivitz, A. Singhal, A. Patel, K. Ayesu, J. Sobierska, H. Santin-Janin, W. Dehaan, R. Azeem, P. Traber, H.S.B. Baraf

Institutions: Altoona Center for Clinical Research, George Washington University

Language: English

Topic: Gout, Hyperuricemia, Uric Acid

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399481509

Cites:

Cited by: 3

Related to: 10